Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
SmartMedia Technologies is the Enterprise SaaS Web3 platform the future is being built on.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Mereo is a new UK-based speciality biopharmaceutical company.
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Life Science, Biopharma, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Definium Therapeutics received $805.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $31.3B.
Janus Henderson Investors's average investment size is $160.4M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Element Biosciences, Elevation Oncology, Jade Biosciences, Entact Bio, Pyxis Oncology. These companies were founded in 2020 or later.